BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 16023430)

  • 1. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 4. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
    Wilson LL
    Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in thin melanoma patients.
    Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
    J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glimpse of future management of melanoma.
    Cochran AJ
    Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
    [No Abstract]   [Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
    Queirolo P; Taveggia P; Gipponi M; Sertoli MR
    J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
    Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

  • 15. Should all melanoma patients undergo sentinel lymph node biopsy?
    Ra JH; McMasters KM; Spitz FR
    Curr Opin Oncol; 2006 Mar; 18(2):185-8. PubMed ID: 16462189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma.
    Ling A; Dawkins R; Bailey M; Leung M; Cleland H; Serpell J; Kelly J
    Australas J Dermatol; 2010 Feb; 51(1):13-7. PubMed ID: 20148833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of early-stage cutaneous melanoma.
    Aloia TA; Gershenwald JE
    Curr Probl Surg; 2005 Jul; 42(7):460-534. PubMed ID: 16099230
    [No Abstract]   [Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
    Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
    Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.